Diabetes Board decisions

The Board has found that the veteran's PTSD and Type II diabetes mellitus were not incurred or aggravated by service, as there is insufficient evidence to support the claimed stressors and no medical evidence linking these conditions to service. The veteran failed to provide sufficient details about his in-service stressors.

The Board dismissed the veteran's claims for increased evaluations of his right and left lower extremity peripheral neuropathy as he did not file a substantive appeal. The diabetes mellitus claim was granted with an initial rating of 40 percent.

The veteran's claim for secondary service connection for numbness and swelling of the left foot was denied. His PTSD claim was granted with a 30% rating.

The veteran's service-connected disabilities, including diabetes mellitus and lumbosacral strain with degenerative disk disease, L5-S1, have been rated appropriately. The TDIU claim has also been granted.

The veteran's appeal is being remanded to the RO for further consideration due to his request for AOJ review of additional evidence.

The veteran's claims for service connection were denied as his conditions are not presumed to be due to herbicide exposure, and he does not have a service-connected disability.

The veteran's appeal for an increased evaluation for diabetes mellitus and service connection for tinea versicolor was denied due to the failure to file a timely substantive appeal.

The veteran's claims for higher ratings and service connection were denied as the conditions did not meet the criteria for a higher rating or direct service connection.

The Board found that the veteran's diabetes mellitus and impotence do not warrant higher ratings based on their current manifestations, as they do not meet the criteria for a higher evaluation under applicable rating criteria.

The Board denied service connection for diabetes mellitus, finding no evidence of exposure to Agent Orange and no medical opinion linking the condition to military service.

The veteran's diabetes mellitus is not considered service-connected due to lack of exposure to herbicide agents during his active duty in Thailand and the failure to establish direct causation.

The Board found that the veteran's death was not caused by a service-connected disability, and thus denied claims for DIC under both 38 U.S.C.A. § 1318 and 38 U.S.C.A. § 1151.

The Board denied the veteran's claim for service connection for diabetes mellitus, finding no evidence of herbicide exposure and noting that his condition was first diagnosed 30 years after separation from military service.

The Board has vacated its previous decision and now remands the case for further action, including scheduling a video conference hearing.

The Board denied service connection for hypertension and residuals of a right ankle injury, as well as benefits under Section 1151 for post-traumatic stress disorder and diabetes mellitus.,VA compensation was also denied for the veteran's below-the-knee amputation.

The veteran's claim for an increased disability rating for diabetes mellitus type II is being remanded due to the need for additional medical records and a VA examination.

The Board has determined that the veteran's diabetes mellitus and left ear hearing loss were not incurred or aggravated by service, including exposure to herbicides. The claim for service connection is denied.

The Board found that the veteran's service-connected diabetes mellitus did not cause or contribute to his death due to a fatal pulmonary embolus. The underlying cause of his death was chronic polyneuropathy with quadriparesis, which is unrelated to his service.

The veteran's claims for earlier effective dates for diabetes mellitus, diabetic neuropathy, and amputation of the left middle finger were denied. The RO has established service connection for these conditions starting from the date of the veteran's claims.,There is no evidence of any earlier filed formal or informal claim for these disabilities.

The RO denied the veteran's claim for an initial rating in excess of 20 percent for diabetes mellitus.